• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Enzymatica

2.53 SEK

+0.40 %

Less than 1K followers

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.40 %
+0.80 %
+22.82 %
+33.16 %
+37.50 %
-16.50 %
+5.23 %
-76.80 %
-55.71 %

Enzymatica is a life science company that develops and sells medical devices against infectious diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray, which can prevent colds and shorten the duration of the illness. The product has been launched in several markets and the strategy is to expand to more markets through partners. The head office is located in Lund.

Read more
Market cap
614.12M SEK
Turnover
135.48K SEK
Revenue
53.9M
EBIT %
-95.3 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16.7
2026

Interim report Q2'26

29.10
2026

Interim report Q3'26

18.2
2027

Annual report '26

Press release6/9/2026, 6:45 AM

Enzymatica appoints Marketing and Sales Director to accelerate ColdZyme’s continued growth in the Nordics

Enzymatica
Regulatory press release5/7/2026, 2:05 PM

Bulletin from annual general meeting of Enzymatica AB (publ) on 7 May 2026

Enzymatica
Regulatory press release4/28/2026, 6:30 AM

Enzymatica AB: Quarterly report Q1/2026 - Enzymatica strengthens international position through STADA agreement

Enzymatica

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/14/2026, 8:00 AM

Enzymatica AB: Enzymatica publishes annual report for 2025

Enzymatica
Regulatory press release3/31/2026, 12:00 PM

Enzymatica AB: Enzymatica and STADA sign partnership agreement for Germany and Austria

Enzymatica
Regulatory press release3/31/2026, 8:45 AM

Notice of Annual General Meeting 2026 in Enzymatica AB (publ)

Enzymatica
Regulatory press release2/18/2026, 7:30 AM

Enzymatica AB: Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion

Enzymatica
Press release12/11/2025, 11:00 AM

Enzymatica AB: Enzymatica appoints Acting CFO during transition period

Enzymatica
Press release11/26/2025, 9:46 AM

BioStock: Enzymatica enters partnership with the UK Sports Institute to strengthen elite athlete health

Enzymatica
Press release11/20/2025, 7:30 AM

Enzymatica AB: Enzymatica enters partnership with the UK Sports Institute to support athlete health and performance

Enzymatica
Press release11/4/2025, 2:13 PM

BioStock: Enzymatica’s CEO steps down after four years – summarizes a journey from science to commercialization

Enzymatica
Regulatory press release10/30/2025, 7:30 AM

Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

Enzymatica
Press release10/15/2025, 7:17 AM

BioStock: Enzymatica launches new ColdZyme flavour

Enzymatica
Press release10/14/2025, 7:25 AM

Enzymatica AB: ColdZyme launches a refreshing new flavour - Eucalyptus

Enzymatica
Regulatory press release10/13/2025, 8:00 AM

Enzymatica AB: Enzymatica appoints Holger Lembrér as new CFO

Enzymatica
Press release10/1/2025, 11:00 AM

Enzymatica AB: Enzymatica to Support Swedish Biathlon Federation as Official Supplier

Enzymatica
Regulatory press release8/22/2025, 11:50 AM

Bulletin from the Extraordinary General Meeting of Enzymatica AB (publ) on 22 August 2025

Enzymatica
Regulatory press release8/12/2025, 6:00 AM

Sana Alajmovic appointed new CEO of Enzymatica AB

Enzymatica
Regulatory press release8/6/2025, 6:30 AM

Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica
Regulatory press release7/17/2025, 6:30 AM

Enzymatica AB: Quarterly report Q2/2025: Strong development in Sweden and increased international activity

Enzymatica